RxDoctor Payments Data

Barry Munsey

Physician Assistant · Staunton, VANPI 1508836933

Payments from drug & device makers

$3,679in general payments, 2019–2025

Across 211 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$972
  • Lilly USA, LLC$585
  • Pfizer$529
  • Novo Nordisk$428
  • Amgen$310
  • Abbott$178
  • plus $678 from 15 others

What the payments were for

  • Food & beverage$3,667100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,679 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$40,115
EliquisApixaban35$29,416
JardianceEmpagliflozin19$20,193
JanuviaSitagliptin Phosphate17$18,197
FarxigaDapagliflozin Propanediol18$14,406
Levothyroxine Sodium187$1,684
FenofibrateFenofibrate,micronized39$1,636
Pantoprazole Sodium117$1,540
Losartan Potassium150$1,158
Olmesartan Medoxomil33$1,099
Gabapentin27$1,027
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid11$981
Ezetimibe56$977
SynthroidLevothyroxine Sodium17$947
Rosuvastatin Calcium118$893

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$428$40,11531 claims
PfizerEliquis$529$29,41635 claims
Boehringer IngelheimJardiance$90$20,19319 claims
MerckJanuvia$14$18,19717 claims
AstraZenecaFarxiga$972$14,40618 claims
AbbVieSynthroid$41$94717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Staunton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →